Anti-fatty liver agent
An anti-fatty liver agent containing a cell and/or a culture of the lactic acid bacterium Latobacillus gasseri as an active ingredient is provided. Also disclosed is a pharmaceutical agent having an anti-fatty liver activity or an anti-fatty liver beverage or food containing a cell and/or a culture of the lactic acid bacterium Latobacillus gasseri as an active ingredient. Methods of treating fatty liver in a subject by administering a cell and/or a culture of the lactic acid bacterium Latobacillus gasseri are also provided.
1. A method of treating fatty liver in a subject in need thereof, comprising administering to the subject an effective amount of lyophilized viable Lactobacillus gasseri cells.
2. The method of claim 1 , comprising administering to the subject a food or beverage comprising the Lactobacillus gasseri cells.
3. The method of claim 1 , wherein the Lactobacillus gasseri is any one of Lactobacillus gasseri SBT2055 (FERM P-15535) and Lactobacillus gasseri SBT0274 (FERM P-17784).
4. The method of claim 1 , wherein the Lactobacillus gasseri cells are administered to the subject orally.
5. The method of claim 1 , wherein the effective amount of Lactobacillus gasseri cells administered to the subject is 0.5 to 50 g dry weight per day.
6. A method for reducing triglyceride levels in the liver of a subject having fatty liver disease, comprising administering to the subject an effective amount of lyophilized viable Lactobacillus gasseri cells.
7. The method of claim 6 , comprising administering to the subject a food or beverage comprising the Lactobacillus gasseri cells.
8. The method of claim 6 , wherein the Lactobacillus gasseri is any one of Lactobacillus gasseri SBT2055 (FERM P-15535) and Lactobacillus gasseri SBT0274 (FERM P-17784).
9. The method of claim 6 , wherein the Lactobacillus gasseri cells are administered to the subject orally.
10. The method of claim 6 , wherein the effective amount of Lactobacillus gasseri cells administered to the subject is 0.5 to 50 g dry weight per day.
11. A method for reducing the amount of liver fat in a subject having fatty liver disease, comprising administering to the subject an effective amount of lyophilized viable Lactobacillus gasseri cells.
12. The method of claim 11 , comprising administering to the subject a food or beverage comprising the Lactobacillus gasseri cells.
13. The method of claim 11 , wherein the Lactobacillus gasseri is any one of Lactobacillus gasseri SBT2055 (FERM P-15535) and Lactobacillus gasseri SBT0274 (FERM P-17784).
14. The method of claim 11 , wherein the Lactobacillus gasseri cells is are administered to the subject orally.
15. The method of claim 11 , wherein the effective amount of Lactobacillus gasseri cells administered to the subject is 0.5 to 50 g dry weight per day.